Clinical Trials List
Protocol NumberCLNP023C12302
NCT Number(ClinicalTrials.gov Identfier)-
Completed
2021-01-13 - 2023-03-06
Phase III
Recruiting2
-
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/23
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
- -
Co-Principal Investigator
- - - Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
4 participants
-
Global
91 participants
